Hayder Hashim

Hayder Hashim

Auto-generated profile, based on publicly available information

Hayder Hashim

Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, District of Columbia

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 February 2022 in The American Journal of Cardiology
Verified
Journal Article
Closed access
BCBrian C. Case
Brian C. Case
BRBenjamin Rosenfeld
Benjamin Rosenfeld
CSCorey Shea
Corey Shea
HRHank Rappaport
Hank Rappaport
CZCheng Zhang
Cheng Zhang
RWRon Waksman
Ron Waksman

23 March 2024 in Catheterization and Cardiovascular Interventions
Verified
Journal Article
Closed access
IMIlan Merdler
Ilan Merdler
RWRyan Wallace
Ryan Wallace
ABAvantika Banerjee
Avantika Banerjee
GMGiorgio A. Medranda
Giorgio A. Medranda
PRPavan Reddy
Pavan Reddy
HHHayder D. Hashim
Hayder D. Hashim

28 August 2021 in The American Journal of Cardiology
Verified
Journal Article
Open access
BCBrian C. Case
Brian C. Case
JAJonathan Abramowitz
Jonathan Abramowitz
CSCorey Shea
Corey Shea
HRHank Rappaport
Hank Rappaport
GMGiorgio A. Medranda
Giorgio A. Medranda
RWRon Waksman
Ron Waksman
The occurrence of venous thromboembolisms in patients with COVID-19 has been established. We sought to evaluate the clinical impact of thrombosis in patients with COVID-19 over the span of the pandemic to date. We analyzed patients with COVID-19 with a diagnosis of thrombosis who presented to the MedStar Health system (11 hospitals in Washington, District of Columbia, and Maryland) during the pandemic (March 1, 2020, to March 31, 2021). We compared the clinical course and outcomes based on the presence or absence of thrombosis and then, specifically, the presence of cardiac thrombosis. The cohort included 11,537 patients who were admitted for COVID-19. Of these patients, 1,248 had noncardiac thrombotic events and 1,009 had cardiac thrombosis (myocardial infarction) during their hospital admission. Of the noncardiac thrombotic events, 562 (45.0%) were pulmonary embolisms, 480 (38.5%) were deep venous thromboembolisms, and 347 (27.8%) were strokes. In the thrombosis arm, the mean age of the cohort was 64.5 ± 15.3 years, 53.3% were men, and the majority were African-American (64.9%). Patients with thrombosis tended to be older with more co-morbidities. The in-hospital mortality rate was significantly higher (16.0%) in patients with COVID-19 with concomitant non-cardiac thrombosis than in those without thrombosis (7.9%, p <0.001) but lower than in patients with COVID-19 with cardiac thrombosis (24.7%, p <0.001). In conclusion, patients with COVID-19 with thrombosis, especially cardiac thrombosis, are at higher risk for in-hospital mortality. However, this prognosis is not as grim as for patients with COVID-19 and cardiac thrombosis. Efforts should be focused on early recognition, evaluation, and intensifying antithrombotic management for these patients.

30 March 2025 in Catheterization and Cardiovascular Interventions
Verified
Journal Article
Closed access
JGJason Galo
Jason Galo
ACAbhishek Chaturvedi
Abhishek Chaturvedi
BVBeni Rai Verma
Beni Rai Verma
KCKalyan R. Chitturi
Kalyan R. Chitturi
DHDan Haberman
Dan Haberman
HHHayder D. Hashim
Hayder D. Hashim

21 August 2021 in CJC Open
Verified
Journal Article
Open access
MSManavotam Singh
Manavotam Singh
NMNeil Mehta
Neil Mehta
FHFatima Hayat
Fatima Hayat
CSCesar E. Soria
Cesar E. Soria
HHHayder Hashim
Hayder Hashim
ABAna Barac
Ana Barac
We report a case of myocarditis in an adult patient with recent coronavirus disease 2019 (COVID-19) infection presenting as recurrent ST-segment elevation, mimicking coronary vasospasm. This case highlights the wide range of presentations of COVID-19–related myocarditis. The novel teaching point is that COVID-19 myocarditis can present with acute manifestations such as chest pain and transient ST-segment elevation even several weeks after complete recovery from the initial infection. Cardiac magnetic resonance imaging should be considered in patients with chest pain syndromes and angiographically normal coronary arteries, as the presence of late gadolinium enhancement and a high T2 signal can be diagnostic. Follow-up cardiac magnetic resonance imaging may be used to assess resolution.

8 August 2022 in Cardiovascular Revascularization Medicine
Verified
Journal Article
Closed access
ADAditya Devineni
Aditya Devineni
GMGebremedhin D. Melaku
Gebremedhin D. Melaku
YKYirga Kahsay
Yirga Kahsay
MFMichael A. Finizio
Michael A. Finizio
SBSolomon S. Beyene
Solomon S. Beyene
HGHector M. Garcia-Garcia
Hector M. Garcia-Garcia